Back to Results

IQVIA Holdings Inc (IQV)

IQVIA Holdings Inc. is a common stock listing on the NYSE tied to a healthcare company focused on services for the life sciences sector. The company supports pharmaceutical, biotechnology, medical device, diagnostic, and consumer health clients across the Americas, Europe, Africa, and the Asia-Pacific region. Its operations are organized into three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions.

Through these businesses, IQVIA provides analytics and consulting, clinical research and trial support, laboratory services, and customer engagement and medical services. The company was previously known as Quintiles IMS Holdings, Inc. and adopted the IQVIA Holdings Inc. name in November 2017. It is based in Durham, North Carolina.


Stock Summary Fair Value Profitability & Growth Quality & Risk Events & Dividends Technical Outlook FAQ

Jump between the core stock analysis sections, valuation data, fair value models, technical outlook, and FAQ.

Data update note: Fair value and stock analysis metrics are updated after regular market sessions when new data becomes available.
Ticker Fair Value Fair Value Upside/Downside Fair Value Rating Analyst Price Target Analyst Target Upside/Downside Analyst Target Rating Overall Financial Health Upcoming Dividend Ex-Date Dividend Payment Date Upcoming Dividend Dividend Yield Next Earnings Date P/E Ratio Price-to-Book Ratio Price-to-Sales Ratio Market Cap Enterprise Value Total Debt / Total Capital Free Float / Shares Outstanding Altman Z-Score Payout Ratio Free Cash Flow / Net Income
NYSE-IQV
$242.50
20.1% Upside
Undervalued
$232
14.9% Upside
Fair
Good
—
—
—
0.0%
July 28, 2026
24.2x
5.4x
2.0x
34.031 B
47.59 B
32.0%
95.0%
4.8
—
152.8%
Valuation • Fair Value

IQVIA Holdings Inc (NYSE-IQV) Fair Value by Valuation Model

Compare the primary fair value estimate for IQVIA Holdings Inc (NYSE-IQV) with model-based valuation references such as DCF, Ben Graham, DDM, EPV and comparable-company valuation.

Primary Valuation Read

Fair Value

$242.50

Estimated upside of 20.1% versus the current market price.

Fair Value Confidence

High

Confidence level for the primary fair value estimate.

DCF Fair Value

$258.49

Discounted cash flow valuation reference.

Ben Graham Formula Value

$92.08

Classic Ben Graham valuation formula reference.

DDM Fair Value

NM

Dividend discount model valuation reference.

EPV Fair Value

NM

Earnings power value estimate.

Comps Fair Value

$226.52

Comparable-company valuation reference.

Analyst Price Target

$232

Analysts imply upside of 14.9%.

How to read these valuation models

Use this section to compare the primary fair value estimate for IQVIA Holdings Inc (NYSE-IQV) with several model-based valuation references. Different models can produce different outputs because each method relies on a different set of assumptions, so the primary fair value estimate should be read alongside the model spread rather than in isolation.

Profitability • Growth

Profitability & Growth for IQVIA Holdings Inc (NYSE-IQV)

A compact read on revenue, forward revenue expectations, EBITDA and operating profitability trends.

Revenue

16.632 B

Current operating scale indicator.

Revenue Forecast

17.271 B

Forward revenue estimate.

EBITDA

3.001 B

Current operating profitability reference.

EBITDA Forecast

4 B

Forward operating profitability estimate.

How to read profitability and growth

This section helps investors review IQVIA Holdings Inc (NYSE-IQV) from an operating perspective by combining current scale, forward revenue expectations and EBITDA-related profitability measures.

Quality • Risk

Quality & Financial Risk for IQVIA Holdings Inc (NYSE-IQV)

Review financial health, earnings quality and balance-sheet risk through Piotroski, Beneish, Altman and cash conversion metrics.

Financial Health

Good

Positive financial-health read.

Piotroski Score

4

Mid-range quality score.

Beneish M-Score

-2.63

No elevated caution signal from this screen.

Altman Z-Score

4.8

Relatively strong balance-sheet zone.

FCF / Net Income

152.8%

Cash conversion quality indicator.

How to read quality and risk

This section combines quality, balance-sheet and accounting-risk indicators for IQVIA Holdings Inc (NYSE-IQV). Read the metrics together: no single score is a complete investment conclusion, but the combined view can highlight financial strength, earnings quality and areas that may deserve closer review.

Events • Dividends

Upcoming Events & Dividends for IQVIA Holdings Inc (NYSE-IQV)

Track the next earnings date, ex-dividend date, dividend payment date, dividend yield and upcoming distribution details where available.

Next Earnings Date

July 28, 2026

Days to Earnings

7

Dividend Payment Date

Not available

Ex-Dividend Date

Not available

Dividend Yield

0.0%

Income yield reference.

Upcoming Dividend

Not available

Data is currently unavailable.

Payment Type

Not available

Data is currently unavailable.

Dividend Currency

Not available

Data is currently unavailable.

Payout Ratio

Not available

Data is currently unavailable.

How to read events and dividends

This section helps investors track time-sensitive items for IQVIA Holdings Inc (NYSE-IQV), including the next earnings date and dividend-related milestones. These items can matter for short-term volatility, income planning and event-driven positioning.

Stock Forecast • Technical Outlook

IQVIA Holdings Inc (NYSE-IQV) Stock Forecast & Technical Outlook

Review IQVIA Holdings Inc (NYSE-IQV) across multiple technical time frames, alongside analyst recommendation data, to form a faster read on market positioning and near-term sentiment.

Technical Signals by Time Frame

Switch between time frames to review the current technical signal for the stock.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 15-minute • intraday
Strong Sell

The 15-minute technical read for IQVIA Holdings Inc (NYSE-IQV) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 1-hour • short-term
Strong Sell

The 1-hour technical read for IQVIA Holdings Inc (NYSE-IQV) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: daily • daily
Neutral

The daily technical read for IQVIA Holdings Inc (NYSE-IQV) is currently Neutral. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: weekly • weekly
Strong Buy

The weekly technical read for IQVIA Holdings Inc (NYSE-IQV) is currently Strong Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: monthly • monthly
Strong Buy

The monthly technical read for IQVIA Holdings Inc (NYSE-IQV) is currently Strong Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Analyst Consensus for IQVIA Holdings Inc (NYSE-IQV)

A consolidated view of buy, hold and sell recommendations based on the currently available analyst data.

Strong Sell Sell Neutral Buy Strong Buy
Consolidated analyst recommendation mix
Strong Buy

Based on the available recommendation mix, IQVIA Holdings Inc (NYSE-IQV) has a Strong Buy consensus, with 15 buy, 3 hold and 0 sell recommendations in the current data set.

Buy 15
Hold 3
Sell 0
FAQ • Fast Investor Answers

IQVIA Holdings Inc (NYSE-IQV) Stock FAQ

Quick answers about IQVIA Holdings Inc (NYSE-IQV) stock, including fair value, valuation rating, analyst price target, dividends, earnings dates, market capitalization, financial health and other key stock analysis metrics.

Fair Value
$242.50
Estimated upside 20.1%
Valuation Rating
Undervalued
Estimated upside of 20.1%
Analyst Target
$232
Implied upside 14.9%
Financial Health
Good
Current financial-health read

The current fair value estimate for IQVIA Holdings Inc (NYSE-IQV) is $242.50. This implies an estimated upside of 20.1% versus the current market price.

Based on the current fair value estimate, the stock appears undervalued, with estimated upside of 20.1% versus the current market price.

The available analyst price target for IQVIA Holdings Inc (NYSE-IQV) is $232. The analyst target implies estimated upside of 14.9%.

The current financial health read for IQVIA Holdings Inc (NYSE-IQV) is Good. This should be reviewed alongside valuation, profitability, debt and cash-flow quality metrics.

The next earnings date currently listed for IQVIA Holdings Inc (NYSE-IQV) is July 28, 2026.

Based on the current data, dividend yield is 0.0%.

The current P/E ratio listed for IQVIA Holdings Inc (NYSE-IQV) is 24.2x. Use it together with growth, margins and sector comparisons rather than as a standalone valuation signal.

The current market capitalization listed for IQVIA Holdings Inc is 34.031 B.

The current enterprise value listed for IQVIA Holdings Inc is 47.59 B. Enterprise value can provide a broader valuation view than market capitalization alone because it also considers net debt.

The ticker symbol for IQVIA Holdings Inc is NYSE-IQV, and the stock is listed on NYSE.

IQVIA Holdings Inc (NYSE-IQV) is listed on NYSE.

The current debt-to-total-capital ratio listed for IQVIA Holdings Inc is 32.0%, which helps investors evaluate the company’s financing structure and leverage profile.

The free float listed for IQVIA Holdings Inc is 95.0%. Free float helps investors understand how much of the share base is available for public trading.

Similar Life Sciences Tools & Services Stocks on NYSE View more

Thermo Fisher Scientific Inc (TMO) Thermo Fisher Scientific Inc (TMO)
Danaher Corporation (DHR) Danaher Corporation (DHR)
Agilent Technologies Inc (A) Agilent Technologies Inc (A)
Waters Corporation (WAT) Waters Corporation (WAT)
Mettler-Toledo International Inc (MTD) Mettler-Toledo International Inc (MTD)
West Pharmaceutical Services Inc (WST) West Pharmaceutical Services Inc (WST)
Revvity Inc (RVTY) Revvity Inc (RVTY)
Charles River Laboratories (CRL) Charles River Laboratories (CRL)
Qiagen NV (QGEN) Qiagen NV (QGEN)
Bio-Rad Laboratories B (BIOb) Bio-Rad Laboratories B (BIOb)
Bio-Rad Laboratories Inc (BIO) Bio-Rad Laboratories Inc (BIO)
Avantor Inc (AVTR) Avantor Inc (AVTR)
Stevanato Group SpA (STVN) Stevanato Group SpA (STVN)
Ginkgo Bioworks Holdings (DNA) Ginkgo Bioworks Holdings (DNA)